AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10588224
Drug: High-dose enalapril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose enalapril (40 mg daily)
Trial: 10588224
Drug: Low-dose enalapril
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose enalapril (5 mg daily)
Trial: 8942297
Drug: Tripotassium dicitrato
RxNorm normalized name: Tripotassium dicitratobismuthate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tripotassium dicitrato bismuthate (240 mg b.i.d.), metronidazole (250 mg t.i.d.), and amoxicillin (500 mg t.i.d.) for 14 days (Group 1)
Trial: 8942297
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg b.i.d.) and amoxicillin (1000 mg b.i.d.) for 14 days (Group 2)
Trial: 8942297
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg b.i.d.), metronidazole (250 mg t.i.d.), and amoxicillin (500 mg t.i.d.) for 14 days (Group 3)
Trial: 8942297
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg q.d.) and amoxicillin (500 mg t.i.d.) for 14 days followed by tripotassium dicitrato bismuthate (240 mg b.i.d.) and nizatidine (150 mg q.d.) for 14 days (Group 4)
Trial: 7068113
Drug: chenodeoxycholic acid
RxNorm normalized name: Chenodeoxycholic acid
DrugBank: Chenodeoxycholic acid (DB06777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: chenodeoxycholic acid (CDCA) 375 or 750 mg g.d. for 2 years
Trial: 29238184
Drug: Baseline pulmonary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline pulmonary maintenance medication
Trial: 27084659
Drug: Proton therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton therapy (arm A)
Trial: 27084659
Drug: Carbon ion
RxNorm normalized name: CARBON ION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbon ion therapy (arm B)
Trial: 27084659
Drug: Both therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both therapies (Proton and Carbon ion)
Trial: 25149894
Drug: Baru almonds
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baru almonds supplementation (20 g/day)
Trial: 25149894
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 corn starch capsule/day)
Trial: 22573845
Drug: AZT/sdNVP (zidovudine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZT/sdNVP (zidovudine until delivery with single-dose nevirapine without postpartum prophylaxis)
Trial: 19509551
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus vitamin B6 PC6 points injection
Trial: 17484670
Drug: Short-term psychodynamic
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term psychodynamic psychotherapy based on supportive-expressive therapy, tailored for social phobia.
Trial: 16531939
Drug: Patient-delivered partner
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-delivered partner treatment (PDPT)
Trial: 9164180
Drug: Vinblastine, methotrexate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinblastine, methotrexate, and bleomycin (VBM) chemotherapy and regional radiotherapy
Trial: 8428718
Drug: Propranolol (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (0.15 mg/kg intravenously)
Trial: 27537387
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral medroxyprogesterone acetate (MPA) for 10 days per cycle
Trial: 27537387
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral MPA daily for 6 months
Trial: 21945889
Drug: HEARTY exercise
RxNorm normalized name: porcine heart preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HEARTY exercise intervention (a combination of healthy eating, aerobic, and resistance exercise)
Trial: 17895895
Drug: Guar gum
RxNorm normalized name: Guar Gum
DrugBank: Guar gum (DB13446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guar gum supplementation (11 g per day)
Trial: 11396814
Drug: Cisapride (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride (0.2 mg/kg dose three times daily)
Trial: 9757196
Drug: Epirubicin (30-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin (30-40 mg)
Trial: 9757196
Drug: Mitoxantrone (6-8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitoxantrone (6-8 mg)
Trial: 3061042
Drug: 4 times
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 times 10 Gy afterloading therapy combined with 45 Gy percutaneous telecobalt therapy
Trial: 3061042
Drug: 5 times
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 times 8 Gy afterloading therapy combined with 45 Gy percutaneous telecobalt therapy
Trial: 3061042
Drug: 8 times
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 times 5 Gy afterloading therapy combined with 45 Gy percutaneous telecobalt therapy
Trial: 8470417
Drug: Nitroglycerin (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (1.2 mg sublingually)
Trial: 8470417
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg capsule, chewed and swallowed)
Trial: 151547
Drug: Salbutamol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (200 microgram four times daily)
Trial: 151547
Drug: Prednisolone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (10 mg three times daily) in addition to both drugs
Trial: 30450642
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg 4MP (fomepizole)
Trial: 24314223
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with vinorelbine plus cisplatin (NP)
Trial: 24314223
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with docetaxel plus cisplatin (TP)
Trial: 19768640
Drug: Budesonide/formoterol (100/6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide/formoterol (100/6 microg) once daily plus additional doses as needed (SMART)
Trial: 19768640
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treated according to guidelines (medium daily doses of ICS plus SABA if needed)
Trial: 11718986
Drug: Tumescent technique
RxNorm normalized name: zinc pyrithione
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tumescent technique with subdermal injections of epinephrine, thrombin spray, and warm saline soaked laparotomy pads.
Trial: 11718986
Drug: Thrombin spray
RxNorm normalized name: thrombin Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombin spray and warm saline soaked laparotomy pads (control group).
Trial: 8124407
Drug: Ephedrine/Caffeine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine/Caffeine combination (20 mg/200 mg) three times a day
Trial: 8124407
Drug: Ephedrine alone
RxNorm normalized name: Ephedrine
DrugBank: Ephedrine (DB01364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ephedrine alone (20 mg) three times a day
Trial: 8124407
Drug: Caffeine alone
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine alone (200 mg) three times a day
Trial: 3306439
Drug: Oxaprotiline (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxaprotiline (150 mg daily for 28 days)
Trial: 3306439
Drug: Clomipramine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomipramine (150 mg daily for 28 days)
Trial: 28165812
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Bupivacaine and Lipid emulsion (Bup1000LE)
Trial: 26063354
Drug: Sarpogrelate (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarpogrelate (100 mg three times daily for 6 months)
Trial: 26063354
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg once daily for 6 months)
Trial: 23242806
Drug: traditional prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: traditional prescription approach
Trial: 10190919
Drug: Anti-neutrophil cytoplasmic
RxNorm normalized name: Anti-neutrophil cytoplasmic antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-neutrophil cytoplasmic antibodies (ANCAs) and anti-Saccharomyces cerevisiae antibodies (ASCA) together
Trial: 7000296
Drug: Atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 100 mg once daily + Chlorthalidone 25 mg once daily
Trial: 28379536
Drug: Tolvaptan (early
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan (early treatment)
Trial: 27111644
Drug: 19-G multiport
RxNorm normalized name: MENTHOL 19 g in 100 TOPICAL PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 19-G multiport wire-reinforced catheter
Trial: 27111644
Drug: 19-G uniport
RxNorm normalized name: MENTHOL 19 g in 100 TOPICAL PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 19-G uniport wire-reinforced catheter
Trial: 22295895
Drug: (R,S)‐Ket (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (R,S)‐Ket (0.5 mg kg⁻¹) infusion for 40 min
Trial: 17698683
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (500 mg/d)
Trial: 16202900
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream applied to the groin 60 minutes before the procedure
Trial: 12362933
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate 3000 mg
Trial: 12362933
Drug: Calcium acetate
RxNorm normalized name: Calcium Acetate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium acetate 2668 mg
Trial: 12362933
Drug: Sevelamer HCl
RxNorm normalized name: SEVELAMER HCL
DrugBank: Sevelamer (DB00658)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevelamer HCl 2821 mg
Trial: 8833208
Drug: Alendronate 5
RxNorm normalized name: ALENDRONATE 5MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 5 mg/day for 3 years
Trial: 8833208
Drug: Alendronate 10
RxNorm normalized name: ALENDRONATE 10MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate 10 mg/day for 3 years
Trial: 12669736
Drug: Alendronate 20
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate 20 mg/day for 2 years followed by 5 mg/day for 1 year
Trial: 7758493
Drug: Potassium salt
RxNorm normalized name: Lactic acid, potassium salt
DrugBank: Potassium lactate (DB09483)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Potassium salt of penicillin V, 50,000 U/kg per day in three divided doses
Trial: 7758493
Drug: Benzathine salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzathine salt of penicillin V, 50,000 U/kg per day in two divided doses
Trial: 7758493
Drug: Benzathine salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzathine salt of penicillin V, 100,000 U/kg per day in two divided doses
Trial: 2265640
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase (within 3 hours)
Trial: 2265640
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase (3-6 hours after onset)
Trial: 7358942
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg lodoxamide ethyl
Trial: 7358942
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg lodoxamide ethyl
Trial: 7410746
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg lodoxamide ethyl
Trial: 22413944
Drug: CZP 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CZP 400 mg
Trial: 22413944
Drug: CZP 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CZP 200 mg
Trial: 28333288
Drug: Vedolizumab induction
RxNorm normalized name: Vedolizumab
DrugBank: Vedolizumab (DB09033)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Vedolizumab induction therapy
Trial: 22793965
Drug: Oral ketoprofen
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ketoprofen 150 mg preemptively administered every 12 hours for two days before surgery
Trial: 22793965
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered every 12 hours for two days before surgery
Trial: 22793965
Drug: Oral ketoprofen
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ketoprofen 150 mg administered every 12 hours for three days post-surgery
Trial: 19117872
Drug: Very early
RxNorm normalized name: Primula veris extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very early surfactant therapy with nasal continuous positive airway pressure
Trial: 17126951
Drug: 6 min
RxNorm normalized name: garlic 6 minim ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 min infusion of vinorelbine
Trial: 12413984
Drug: Dexamethasone (DEX)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DEX) combined with clomiphene citrate (CC)
Trial: 12413984
Drug: Placebo combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo combined with clomiphene citrate (CC)
Trial: 25128004
Drug: Relating therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relating therapy (16 hours, weekly sessions of one hour)
Trial: 22946700
Drug: Individualised goal-directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualised goal-directed therapy targeting stroke volume and oxygen delivery
Trial: 16635606
Drug: Statins (atorvastatin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statins (atorvastatin, fluvastatin, lovastatin, pravastatin, rosuvastatin, or simvastatin)
Trial: 9093230
Drug: Adjunctive corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive corticosteroid therapy
Trial: 2953312
Drug: 0.75% metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75% metronidazole gel applied twice daily
Trial: 29444376
Drug: Secukinumab 300
RxNorm normalized name: secukinumab 300 MG in 2 ML Auto-Injector
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab 300 mg (every 4 weeks)
Trial: 17486470
Drug: Estrogen plus
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen plus progesterone therapy (EPT)
Trial: 14670288
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy with 8-, 15-, and 20-day induction protocols
Trial: 14670288
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group receiving symptomatic treatments
Trial: 2061979
Drug: Thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic therapy administered to 733 patients
Trial: 2061979
Drug: No thrombolytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No thrombolytic therapy (1498 patients)
Trial: 24680228
Drug: Immediate individual
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate individual cognitive-behavioral therapy for BDD (CBT-BDD), 22 sessions over 24 weeks
Trial: 24680228
Drug: Immediate individual
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate individual cognitive-behavioral therapy for BDD (CBT-BDD)
Trial: 15485012
Drug: Lumiracoxib 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumiracoxib 200 mg once daily
Trial: 7807693
Drug: Imipenem/cilastatin sodium
RxNorm normalized name: imipenem/cilastatin sodium 250 mg INTRAVEN VIAL (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem/cilastatin sodium 1 g/1 g b.i.d.
Trial: 7807693
Drug: Imipenem/cilastatin sodium
RxNorm normalized name: imipenem/cilastatin sodium 250 mg INTRAVEN VIAL (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem/cilastatin sodium 0.5 g/0.5 g q.i.d.
Trial: 3042876
Drug: BS-WC vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BS-WC vaccine
Trial: 2665350
Drug: WC-only vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WC-only vaccine
Trial: 15825396
Drug: Isoprinosine, 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoprinosine, 6 g a day for 2 days prior to challenge and for 7 post-challenge days
Trial: 30935260
Drug: Phototherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phototherapy plus Narrowband UVB plus oral silymarin
Trial: 31820598
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus auricular therapy group
Trial: 31820598
Drug: Auricular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular therapy group
Trial: 11715353
Drug: Ramipril 2.5
RxNorm normalized name: ramipril 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 2.5 mg/day
Trial: 11715353
Drug: Ramipril 10
RxNorm normalized name: ramipril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 10 mg/day
Trial: 23532746
Drug: MK-8998 12/16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-8998 12/16 mg daily
Trial: 23532746
Drug: Olanzapine 10/15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine 10/15 mg daily
Trial: 21395892
Drug: Crushed buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed buprenorphine (2 mg)
Trial: 21395892
Drug: Crushed buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed buprenorphine (8 mg)
Trial: 21395892
Drug: Crushed buprenorphine/naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed buprenorphine/naloxone (2/0.5 mg)
Trial: 21395892
Drug: Crushed buprenorphine/naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed buprenorphine/naloxone (8/2 mg)
Trial: 21395892
Drug: Intravenous buprenorphine/naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous buprenorphine/naloxone (0.8 mg buprenorphine/0.2 mg naloxone)
Trial: 21395892
Drug: All intranasal
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All intranasal doses
Trial: 10919340
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg enalapril wafer
Trial: 10919340
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg enalapril tablet
Trial: 28457847
Drug: Mechanical curettage
RxNorm normalized name: PIPERONYL BUTOXIDE TECHNICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mechanical curettage + adjunct antimicrobial photodynamic therapy (MC + aPDT)
Trial: 26054138
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of midodrine hydrochloride tablets, 2.5 mg per treatment, three times each day for 4 weeks.
Trial: 19506195
Drug: Medication use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication use associated with DED
Trial: 15671911
Drug: High doses
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High doses of vitamin C
Trial: 9793662
Drug: Morphine-bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine-bupivacaine
Trial: 25813765
Drug: Riociguat (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riociguat (up to 2.5 mg 3 times a day for 16 weeks)
Trial: 20400552
Drug: Intensive comparison
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive comparison therapy
Trial: 19209016
Drug: Standard antiemetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antiemetic prophylaxis (5-HT3 receptor antagonist and dexamethasone)
Trial: 17986903
Drug: Cr-Protein-Carbohydrate (Cr-PRO-CHO)
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cr-Protein-Carbohydrate (Cr-PRO-CHO) supplement (1.5 g x kg(‐1) body weight x d(‐1) and 0.1 g x kg(‐1) body weight x d(‐1) of creatine)
Trial: 17986903
Drug: Protein-Carbohydrate (PRO-CHO)
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein-Carbohydrate (PRO-CHO) supplement
Trial: 17986903
Drug: Protein (PRO)
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein (PRO) supplement
Trial: 12040275
Drug: Chemoradiation (radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoradiation (radiation plus chemotherapy)
Trial: 12040275
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy alone (control arm)
Trial: 9660430
Drug: Oral micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral micronized DHEA (25 mg/d)